![Ian Dixon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ian Dixon
Direktor/Vorstandsmitglied bei
NYRADA INC.
Vermögen: 3 Mio $ am 30.06.2026
Profil
Ian Dixon was the founder of Genscreen Pty Ltd. founded in 2002, Cynata, Inc. founded in 2011, Exopharm Ltd. founded in 2013 where Dr. Dixon was Chief Executive Officer, Director & MD from 2013 to 2024, and Cardio Therapeutics Pty Ltd. founded in 2014.
Dr. Dixon is currently Managing Director at Altnia Holdings Pty Ltd., Independent Non-Executive Director at Nyrada, Inc. since 2020, and a Member of the Australia Institute of Co. Directors.
Former positions include Executive Director at Medigard Ltd., Director-Product Group at Vision Systems Pty Ltd., Non-Executive Director at Cell Therapies Pty Ltd., Non-Executive Director at Noxopharm Ltd. from 2016 to 2020, and Owner at Cynata Therapeutics Ltd. Education includes a doctorate from Monash University and undergraduate and MBAistration degrees from Swinburne University of Technology.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NYRADA, INC. 8,94 % | 20.02.2026 | 9.780.699 ( 8,94 % ) | 3 Mio $ | 30.06.2026 |
Aktive Positionen von Ian Dixon
| Unternehmen | Position | Beginn |
|---|---|---|
| NYRADA INC. | Direktor/Vorstandsmitglied | 01.09.2020 |
Altnia Holdings Pty Ltd.
 Altnia Holdings Pty Ltd. Investment ManagersFinance Provides investment services | Corporate Officer/Principal | - |
Australia Institute of Co. Directors | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Ian Dixon
| Unternehmen | Position | Ende |
|---|---|---|
| EXOPHARM | Gründer | 01.05.2024 |
| NOXOPHARM LIMITED | Direktor/Vorstandsmitglied | 31.08.2020 |
Genscreen Pty Ltd. | Gründer | 01.01.2018 |
| CYNATA THERAPEUTICS LIMITED | Corporate Officer/Principal | - |
Cardio Therapeutics Pty Ltd.
 Cardio Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Gründer | - |
Ausbildung von Ian Dixon
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
90
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Medigard Ltd.
 Medigard Ltd. Packaged SoftwareTechnology Services Engages in the development of innovative medical technologies | Technology Services |
Vision Systems Pty Ltd.
 Vision Systems Pty Ltd. Medical SpecialtiesHealth Technology Develops, manufactures, & distributes technology products and services to healthcare markets | Health Technology |
Monash University
 Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swinburne University of Technology
 Swinburne University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cynata Therapeutics Ltd.
 Cynata Therapeutics Ltd. BiotechnologyHealth Technology Engages in stem cell research and development services | Health Technology |
Cell Therapies Pty Ltd. | |
Australia Institute of Co. Directors | |
Cynata, Inc.
 Cynata, Inc. Miscellaneous Commercial ServicesCommercial Services Engaged in stem cell research and development services | Commercial Services |
Genscreen Pty Ltd. | |
Noxopharm Ltd.
 Noxopharm Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer treatment | Health Technology |
Altnia Holdings Pty Ltd.
Altnia Holdings Pty Ltd. Investment ManagersFinance Provides investment services | Finance |
Cardio Therapeutics Pty Ltd.
Cardio Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Nyrada, Inc.
 Nyrada, Inc. Pharmaceuticals: MajorHealth Technology Operates as pre-clinical stage drug development company, specializes in development of novel small molecule drugs | Health Technology |
Exopharm Ltd.
 Exopharm Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of exosomes as therapeutic agent | Health Technology |
